Presentation TCT 2017 Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans Presenter: Francesco Maisano October 31, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Mitral Valve Up Next Presentation TCT 2017 Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices Presenter: Howard C. Herrmann October 31, 2017 More slides + Presentation TCT 2017 Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities? Presenter: Larry L. Wood October 31, 2017 Presentation TCT 2017 Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences Presenter: Martin B. Leon October 31, 2017 We Recommend
Presentation TCT 2017 Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices Presenter: Howard C. Herrmann October 31, 2017
Presentation TCT 2017 Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities? Presenter: Larry L. Wood October 31, 2017
Presentation TCT 2017 Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences Presenter: Martin B. Leon October 31, 2017